Free Trial
NASDAQ:CYTH

Cyclo Therapeutics (CYTH) Stock Price, News & Analysis

Cyclo Therapeutics logo
$0.72 0.00 (0.00%)
As of 03/26/2025

About Cyclo Therapeutics Stock (NASDAQ:CYTH)

Key Stats

Today's Range
$0.72
$0.72
50-Day Range
$0.72
$0.72
52-Week Range
$0.55
$1.45
Volume
N/A
Average Volume
543,848 shs
Market Capitalization
$23.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$0.95
Consensus Rating
Hold

Company Overview

Receive CYTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyclo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CYTH Stock News Headlines

Banks aren’t ready for this altcoin—are you?
I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. This is about being in the right place at the right time – and I believe that time is now.
10 Best Micro Cap Stocks to Buy Now
See More Headlines

CYTH Stock Analysis - Frequently Asked Questions

Cyclo Therapeutics' stock was trading at $0.59 at the beginning of 2025. Since then, CYTH stock has increased by 22.1% and is now trading at $0.7206.
View the best growth stocks for 2025 here
.

Cyclo Therapeutics, Inc. (NASDAQ:CYTH) issued its quarterly earnings data on Thursday, August, 15th. The company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.14) by $0.07. The company earned $0.12 million during the quarter, compared to the consensus estimate of $0.40 million.

Shares of CYTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyclo Therapeutics investors own include Rolls-Royce Holdings PLC (RYCEY), Blink Charging (BLNK), Ford Motor (F), Alphabet (GOOG), Cassava Sciences (SAVA), Zoom Communications (ZM) and Fisker (FSR).

Company Calendar

Last Earnings
8/15/2024
Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CYTH
Employees
9
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$0.95
High Stock Price Target
$0.95
Low Stock Price Target
$0.95
Potential Upside/Downside
+31.8%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.06 million
Net Margins
-2,847.19%
Pretax Margin
-2,847.30%

Debt

Sales & Book Value

Annual Sales
$870.73 thousand
Price / Cash Flow
N/A
Book Value
$0.21 per share
Price / Book
3.43

Miscellaneous

Free Float
23,116,000
Market Cap
$23.72 million
Optionable
No Data
Beta
-0.57
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CYTH) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners